![](https://www.redoxengine.com/wp-content/uploads/2024/01/DHT_Ryan-Halstead-web.jpg)
In this episode of Diagnosing Healthtech, we break down the 2024 J.P. Morgan Healthcare conference.
Former healthcare services analyst and current corporate advisor to private and public equity investors, Ryan Halsted of the Gilman Group joins Jeff to break down themes and takeaways from the conference including:
- VC, P/E funding and IPOs
- AI in healthcare and infiltration of big tech
- The pressure on Medicare advantage
- Potential regulation in pharmacy benefit management
Subscribe for DHT email updates
Related Posts
Redox
Changelog
Redox FHIR API search update
We’re excited to announce an update to the Redox FHIR API that enhances data query capabilities by no longer filtering unrecognized search parameters. This change gives you greater control over your data interactions and improves integrations with downstream systems.
By Elizabeth Ojo – July 16, 2024